Sign in to see private stats on your profile page — or add photo, interests, videos, mentoring, etc.

    Rupal Shah, MD

    TitleAssistant Professor
    SchoolUCSF School of Medicine
    DepartmentMedicine
    Address350 Parnassus
    San Francisco CA 94117
    vCardDownload vCard

      Collapse Biography 
      Collapse Education and Training
      Wayne State UniversitySchool of Medicine2005
      NYP-Columbia UniversityInternal Medicine2008
      University of PennsylvaniaPulmonary and Critical Care2012

      Collapse Overview 
      Collapse Overview
      Dr. Rupal Shah is Assistant Professor of Medicine in the Division of Pulmonary, Critical Care, Allergy and Sleep Medicine. She serves as an attending physician in the Lung Transplant Program and the Interstitial Lung Disease Program. She specializes in care of patients with advanced lung disease, both before and after lung transplantation.
      Dr. Shah received her undergraduate degree from University of Michigan, and a Masters in Clinical Epidemiology from University of Pennsylvania. She completed medical school at Wayne State University School of Medicine and did her internal medicine residency at Columbia University and advanced training in pulmonary and critical care medicine at University of Pennsylvania. She is board certified in Internal Medicine, Pulmonary Medicine, and Critical Care Medicine.

      Collapse Interests
      Lung Transplantation, Primary Graft Dysfunction, Interstitial Lung Disease, Advanced Lung Disease, Chronic Rejection

      Collapse ORNG Applications 
      Collapse Featured Publications

      Collapse Bibliographic 
      Collapse Publications
      Publications listed below are automatically derived from MEDLINE/PubMed and other sources, which might result in incorrect or missing publications. Researchers can login to make corrections and additions, or contact us for help.
      List All   |   Timeline
      1. Singer JP, Katz PP, Soong A, Shrestha P, Huang D, Ho J, Mindo M, Greenland JR, Hays SR, Golden J, Kukreja J, Kleinhenz ME, Shah RJ, Blanc PD. The Effect of Lung Transplantation on Health Related Quality of Life in the Era of the Lung Allocation Score: A U.S. Prospective Cohort Study. Am J Transplant. 2016 Oct 15. PMID: 27743488.
        View in: PubMed
      2. Shah RJ, Diamond JM, Cantu E, Flesch J, Lee JC, Lederer DJ, Lama VN, Orens J, Weinacker A, Wilkes DS, Roe D, Bhorade S, Wille KM, Ware LB, Palmer SM, Crespo M, Demissie E, Sonnet J, Shah A, Kawut SM, Bellamy SL, Localio AR, Christie JD. Objective Estimates Improve Risk Stratification for Primary Graft Dysfunction after Lung Transplantation. Am J Transplant. 2015 Aug; 15(8):2188-96. PMID: 25877792.
        View in: PubMed
      3. Singer JP, Peterson ER, Snyder ME, Katz PP, Golden JA, D'Ovidio F, Bacchetta M, Sonett JR, Kukreja J, Shah L, Robbins H, Van Horn K, Shah RJ, Diamond JM, Wickersham N, Sun L, Hays S, Arcasoy SM, Palmer SM, Ware LB, Christie JD, Lederer DJ. Body composition and mortality after adult lung transplantation in the United States. Am J Respir Crit Care Med. 2014 Nov 1; 190(9):1012-21. PMID: 25233138; PMCID: PMC4299586.
      4. Cantu E, Shah RJ, Lin W, Daye ZJ, Diamond JM, Suzuki Y, Ellis JH, Borders CF, Andah GA, Beduhn B, Meyer NJ, Ruschefski M, Aplenc R, Feng R, Christie JD. Oxidant stress regulatory genetic variation in recipients and donors contributes to risk of primary graft dysfunction after lung transplantation. J Thorac Cardiovasc Surg. 2015 Feb; 149(2):596-602. PMID: 25439478; PMCID: PMC4346512 [Available on 02/01/16].
      5. Kimple AJ, Austin GK, Shah RN, Welch CM, Funkhouser WK, Zanation AM, Shockley WW. Polymorphous low-grade adenocarcinoma: a case series and determination of recurrence. Laryngoscope. 2014 Dec; 124(12):2714-9. PMID: 25229805; PMCID: PMC4547589 [Available on 12/01/15].
      6. Shah RJ, Emtiazjoo AM, Diamond JM, Smith PA, Roe DW, Wille KM, Orens JB, Ware LB, Weinacker A, Lama VN, Bhorade SM, Palmer SM, Crespo M, Lederer DJ, Cantu E, Eckert GJ, Christie JD, Wilkes DS. Plasma complement levels are associated with primary graft dysfunction and mortality after lung transplantation. Am J Respir Crit Care Med. 2014 Jun 15; 189(12):1564-7. PMID: 24930532; PMCID: PMC4226014.
      7. Cohen DG, Christie JD, Anderson BJ, Diamond JM, Judy RP, Shah RJ, Cantu E, Bellamy SL, Blumenthal NP, Demissie E, Hopkins RO, Mikkelsen ME. Cognitive function, mental health, and health-related quality of life after lung transplantation. Ann Am Thorac Soc. 2014 May; 11(4):522-30. PMID: 24605992; PMCID: PMC4225794.
      8. Diamond JM, Akimova T, Kazi A, Shah RJ, Cantu E, Feng R, Levine MH, Kawut SM, Meyer NJ, Lee JC, Hancock WW, Aplenc R, Ware LB, Palmer SM, Bhorade S, Lama VN, Weinacker A, Orens J, Wille K, Crespo M, Lederer DJ, Arcasoy S, Demissie E, Christie JD. Genetic variation in the prostaglandin E2 pathway is associated with primary graft dysfunction. Am J Respir Crit Care Med. 2014 Mar 1; 189(5):567-75. PMID: 24467603; PMCID: PMC3977709.
      9. Shah RJ, Wickersham N, Lederer DJ, Palmer SM, Cantu E, Diamond JM, Kawut SM, Lama VN, Bhorade S, Crespo M, Demissie E, Sonett J, Wille K, Orens J, Weinacker A, Shah P, Arcasoy S, Wilkes DS, Christie JD, Ware LB. Preoperative plasma club (clara) cell secretory protein levels are associated with primary graft dysfunction after lung transplantation. Am J Transplant. 2014 Feb; 14(2):446-52. PMID: 24400993; PMCID: PMC3946770.
      10. Shah RJ, Diamond JM, Cantu E, Lee JC, Lederer DJ, Lama VN, Orens J, Weinacker A, Wilkes DS, Bhorade S, Wille KM, Ware LB, Palmer SM, Crespo M, Localio AR, Demissie E, Kawut SM, Bellamy SL, Christie JD. Latent class analysis identifies distinct phenotypes of primary graft dysfunction after lung transplantation. Chest. 2013 Aug; 144(2):616-22. PMID: 23429890; PMCID: PMC3734891.
      11. Shah RJ, Kotloff RM. Lung transplantation for obstructive lung diseases. Semin Respir Crit Care Med. 2013 Jun; 34(3):288-96. PMID: 23821504.
        View in: PubMed
      12. Cantu E, Lederer DJ, Meyer K, Milewski K, Suzuki Y, Shah RJ, Diamond JM, Meyer NJ, Tobias JW, Baldwin DA, Van Deerlin VM, Olthoff KM, Shaked A, Christie JD. Gene set enrichment analysis identifies key innate immune pathways in primary graft dysfunction after lung transplantation. Am J Transplant. 2013 Jul; 13(7):1898-904. PMID: 23710539; PMCID: PMC3954988.
      13. Shah RJ, Bellamy SL, Lee JC, Cantu E, Diamond JM, Mangalmurti N, Kawut SM, Ware LB, Christie JD. Early plasma soluble receptor for advanced glycation end-product levels are associated with bronchiolitis obliterans syndrome. Am J Transplant. 2013 Mar; 13(3):754-9. PMID: 23331756; PMCID: PMC3582806.
      14. Diamond JM, Lee JC, Kawut SM, Shah RJ, Localio AR, Bellamy SL, Lederer DJ, Cantu E, Kohl BA, Lama VN, Bhorade SM, Crespo M, Demissie E, Sonett J, Wille K, Orens J, Shah AS, Weinacker A, Arcasoy S, Shah PD, Wilkes DS, Ware LB, Palmer SM, Christie JD. Clinical risk factors for primary graft dysfunction after lung transplantation. Am J Respir Crit Care Med. 2013 Mar 1; 187(5):527-34. PMID: 23306540; PMCID: PMC3733407.
      15. Diamond JM, Porteous MK, Cantu E, Meyer NJ, Shah RJ, Lederer DJ, Kawut SM, Lee J, Bellamy SL, Palmer SM, Lama VN, Bhorade SM, Crespo M, Demissie E, Wille K, Orens J, Shah PD, Weinacker A, Weill D, Arcasoy S, Wilkes DS, Ware LB, Christie JD. Elevated plasma angiopoietin-2 levels and primary graft dysfunction after lung transplantation. PLoS One. 2012; 7(12):e51932. PMID: 23284823; PMCID: PMC3526525.
      16. Shah RJ, Diamond JM, Lederer DJ, Arcasoy SM, Cantu EM, Demissie EJ, Kawut SM, Kohl B, Lee JC, Sonett J, Christie JD, Ware LB. Plasma monocyte chemotactic protein-1 levels at 24 hours are a biomarker of primary graft dysfunction after lung transplantation. Transl Res. 2012 Dec; 160(6):435-42. PMID: 22989614; PMCID: PMC3500407.
      17. Diamond JM, Meyer NJ, Feng R, Rushefski M, Lederer DJ, Kawut SM, Lee JC, Cantu E, Shah RJ, Lama VN, Bhorade S, Crespo M, Demissie E, Sonett J, Wille K, Orens J, Weinacker A, Weill D, Arcasoy S, Shah PD, Belperio JA, Wilkes D, Ware LB, Palmer SM, Christie JD. Variation in PTX3 is associated with primary graft dysfunction after lung transplantation. Am J Respir Crit Care Med. 2012 Sep 15; 186(6):546-52. PMID: 22822025; PMCID: PMC3480532.
      18. Shah RJ, Bellamy SL, Localio AR, Wickersham N, Diamond JM, Weinacker A, Lama VN, Bhorade S, Belperio JA, Crespo M, Demissie E, Kawut SM, Wille KM, Lederer DJ, Lee JC, Palmer SM, Orens J, Reynolds J, Shah A, Wilkes DS, Ware LB, Christie JD. A panel of lung injury biomarkers enhances the definition of primary graft dysfunction (PGD) after lung transplantation. J Heart Lung Transplant. 2012 Sep; 31(9):942-9. PMID: 22694851; PMCID: PMC3418416.
      Rupal's Networks
      Related Concepts
      Derived automatically from this person's publications.
      _
      Co-Authors
      People in Profiles who have published with this person.
      _
      Related Authors
      People who share related concepts with this person.
      _
      Back to TOP